TABLE OF CONTENTS 
I. INTRODUCTION 
II. OBJECTIVES 
III. CELL CULTURE METHODS AN PREPARATION OF CELLS FOR ADMINISTRATION 
IV. ELIGIBILITY/EXCLUSIONS 
V. STUDY DESIGN 
VI. STUDY ENDPOINTS AND MONITORING 
VII. CRITERIA FOR RESPONSE 
VIII. CRITERIA FOR DISCONTINUATION OF TREATMENT 
IX. REPORTING OF ADVERSE DRUG REACTIONS 
X. STATISTICAL SECTION 
XI. COLLECTION OF DATA AND DATA SUBMISSION 
XII. REFERENCES. 
XIII. INFORMED CONSENT FORM 
APPENDIX 1 BCMGNeo-B7 vector 
APPENDIX 2 CMV-B7 vector 
APPENDIX 3 Study Schema 
APPENDIX 4 NCI Common Toxicity Criteria 
.3 
12 
12 
13 
15 
17 
19 
19 
20 
20 
20 
21 
23 
[720] 
Recombinant DNA Research, Volume 18 
